OPTIMIZERx Announces Record Preliminary 2013 Third Quarter Results and Update
08 Oktober 2013 - 6:26PM
Marketwired
OPTIMIZERx Announces Record Preliminary 2013 Third Quarter Results
and Update
ROCHESTER, MI--(Marketwired - Oct 8, 2013) - OPTIMIZERx
Corp. (OTCQB: OPRX) today announced preliminary 2013 third quarter
results.
The Company is forecasting third quarter 2013 revenue of
approximately $1.370 million, bringing revenue for the nine months
of 2013 to approximately $3.142 million -- an increase of 240% over
same nine month period in 2012, when revenue was $1.298
million.
The revenues were driven primarily by the Company's SampleMD
solution, which generated approximately 324,756 new ePrescriptions
with co-pay coupons or free sample vouchers during the third
quarter, helping patients more affordably start and stay on their
prescribed medications. That is a substantial increase from
the 265,628 distributions in Q2 2013, and more than tripled from
the 90,135 distributions in Q3 2012.
The Company's Chairman, Mr. David Harrell, stated, "We are very
excited for the continued growth we're experiencing in all facets
of our business, evidenced by another record quarter. We anticipate
continued growth in 2014 and beyond as we expand our electronic
pipeline to deliver savings and product support to hundreds of
thousands of doctors -- right at point of care."
OPTIMIZERx Corp. provides unique consumer and physician
platforms to help patients better afford and comply with their
medicines and healthcare products, while offering pharmaceutical
and healthcare companies effective ways to expand patient
awareness, access and adherence to their brands. For more
information, please go to www.optimizerxcorp.com.
'SAFE HARBOR'
This press release contains forward-looking statements within
the definition of Section 27A of the Securities Act of 1933, as
amended and such section 21E of the Securities Act of 1934,
amended. These forward-looking statements should not be used to
make an investment decision. The words 'estimate,' 'possible' and
'seeking' and similar expressions identify forward-looking
statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise
any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are
inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or
underlying the forward-looking statements. The risks and
uncertainties to which forward-looking statements are subject
include, but are not limited to, the effect of government
regulation, competition and other material risks.
Company Contact: Gabrielle Sabatini Email Contact
248.651.6568
Investor Contact: Chris Schreiber Email Contact
917.445.6207
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024